Lista de obras -

A rare case of acute myeloid leukemia with t(12;19)(q13;q13)

artículo científico publicado en 2020

ALK-rearranged adenocarcinoma transformed to small-cell lung cancer: a new entity with specific prognosis and treatment?

artículo científico publicado en 2018

Acquired factor inhibitor in a patient with monoclonal gammopathy of undetermined significance responding to rituximab.

artículo científico publicado en 2015

Acute myeloid leukemia transformed to a targetable disease

scientific article published on 16 April 2020

Adding checkpoint inhibitors to tyrosine kinase inhibitors targeting EGFR/ALK in non-small cell lung cancer: a new therapeutic strategy

artículo científico publicado en 2016

Adenoid cystic carcinoma of the breast - an aggressive presentation with pulmonary, kidney, and brain metastases: a case report

artículo científico publicado en 2017

Adjuvant tyrosine kinase inhibitors for renal cell carcinoma? No, thank you (at least for the present) reply

scientific article published on 01 August 2018

Agnostic biomarkers in gastrointestinal tumors: microsatellite instability and NTRK

scientific article published on 30 October 2020

Anal cancer treatment: current status and future perspectives

artículo científico publicado en 2015

Are virus-induced cancers more sensitive to checkpoint inhibitors?

artículo científico publicado en 2016

Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status

artículo científico publicado en 2017

BRAFV600 mutant non-small-cell lung cancer resistant to Vemurafenib

artículo científico publicado en 2015

Bioethical considerations for cancer patients care during the COVID-19 pandemic

artículo científico publicado en 2020

Biomarkers for adverse events associated with immune checkpoint inhibitors

artículo científico publicado en 2016

Bladder and vaginal transitional cell carcinoma: A case report

scientific article published on 20 July 2016

Bladder cancer knowledge in the Lebanese population: When ignorance could be harmful

scientific article published on 26 September 2018

Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence

scientific article published on 22 April 2020

Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO).

artículo científico publicado en 2016

Central Macular Thickness Monitoring after a Taxane-Based Therapy in Visually Asymptomatic Patients.

artículo científico publicado en 2017

Characteristic and outcomes of patients with pathologic complete response after preoperative treatment in borderline and locally advanced pancreatic adenocarcinoma: An AGEO multicentric retrospective cohort

scientific article published on 24 April 2019

Charcot-Marie-Tooth hereditary neuropathy revealed after administration of docetaxel in advanced breast cancer

artículo científico publicado en 2017

Checkpoint inhibitors in bladder and renal cancers: results and perspectives.

artículo científico publicado en 2015

Checkpoint inhibitors in gastrointestinal cancers: Expectations and reality

artículo científico publicado en 2017

Checkpoint inhibitors in the treatment of brain metastases of non-small-cell lung cancer and melanoma

artículo científico publicado en 2017

Complete Disappearance of Choroidal Metastasis from Lung Adenocarcinoma Treated with Bevacizumab and Chemotherapy

artículo científico publicado en 2015

Concurrent driver mutations/rearrangements in non-small-cell lung cancer

artículo científico publicado en 2016

Dermatologic adverse events of checkpoint inhibitors: what an oncologist should know

artículo científico publicado en 2016

Diagnosis and treatment of lymphomas in the era of epigenetics

artículo científico publicado en 2020

Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon

artículo científico publicado en 2016

Dilemma of first line regimens in metastatic pancreatic adenocarcinoma

artículo científico publicado en 2016

Disappearance of Upper Urinary Tract Urothelial Carcinoma after Treatment of a Borderline Brenner Tumor: Case Report and Literature Review

artículo científico

Distribution and Characteristics of Pulmonary Neuroendocrine Tumors: Single Institution Experience in Lebanon

artículo científico publicado en 2016

Do checkpoint inhibitors provide new hope for management of metastatic penile carcinoma?

artículo científico publicado en 2018

Do immune-related adverse events correlate with response to immune checkpoint inhibitors?

scientific article published on 01 March 2019

Double pancreatic and gastric adenocarcinomas: a rare association

artículo científico publicado en 2012

EARLY INCREASE of CA 19-9 in ADVANCED PANCREATIC CANCER RECEIVING FOLFIRINOX. Is it a sign of efficacy?

scientific article published on 01 August 2016

EGFR mutation status in Middle Eastern patients with non-squamous non-small cell lung carcinoma: A single institution experience

artículo científico publicado en 2015

Electronic patient-reported outcomes: a revolutionary strategy in cancer care

artículo científico publicado en 2017

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib.

artículo científico publicado en 2017

Epidemiologic and histologic characteristics of CNS lesions: a 20-year experience of a tertiary center in Lebanon

artículo científico publicado en 2020

Express approval of immune checkpoint inhibitors: a conflict between science and finance

artículo científico publicado en 2016

FOLFIRINOX: a new standard of care in the adjuvant setting of resectable pancreatic adenocarcinomas

scientific article published on 12 June 2019

Factor XIII deficiency revealed by spontaneous intramedullary hemorrhage: confirmation of a severe mutation

artículo científico publicado en 2015

Finally, after decades, immune checkpoint inhibitors dethroned the standard of care of small-cell lung cancer

artículo científico publicado en 2019

Gastrointestinal cancers in the era of theranostics: Updates and future perspectives

artículo científico publicado en 2015

Geriatric cancer trends in the Middle-East: Findings from Lebanese cancer projections until 2025.

artículo científico publicado en 2017

Histologic Distribution of Pulmonary Tumors in Lebanon: A 5-Year Single Institution Experience.

artículo científico publicado en 2015

How and when adjuvant treatment should be intensified in stage III colorectal cancers?

artículo científico

Immune checkpoint inhibitors in ocular melanomas: contrasting efficacy with cutaneous melanomas

artículo científico publicado en 2020

Immune checkpoint inhibitors renal side effects and management

artículo científico publicado en 2016

Immune checkpoint inhibitors side effects and management

artículo científico publicado en 2016

Immunotherapies in sarcoma: Updates and future perspectives

artículo científico publicado en 2017

Immunotherapy: last bullet in platinum refractory germ cell testicular cancer

scientific article published on 09 January 2019

Impact of the new World Health Organization classification concept of neuroendocrine tumors

artículo científico publicado en 2017

Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis

artículo científico publicado en 2016

Improved survival in patients with CALR1 compared to CALR2 mutated primary myelofibrosis: a meta-analysis

artículo científico publicado en 2016

Incidence and Risk Factors of Ocular Hypertension following Pars Plana Vitrectomy and Silicone Oil Injection

scientific article published on 23 July 2018

Informational Needs of Women with Breast Cancer Treated with Chemotherapy

artículo científico publicado en 2016

Intravitreal bevacizumab for retinal capillary hemangioblastoma: A case series and literature review

artículo científico

Is gut microbiome a predictive marker to response to immune checkpoint inhibitors?

artículo científico publicado en 2017

Is metastatic pancreatic cancer an untargetable malignancy?

artículo científico publicado en 2016

Is ramucirumab still the only second-line treatment in metastatic gastric cancer?

artículo científico publicado en 2020

Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma? A case report and literature review

artículo científico publicado en 2017

Kidney cancer in Lebanon: a specific histological distribution?

artículo científico publicado en 2015

Learning from the "tsunami" of immune checkpoint inhibitors in 2015.

artículo científico publicado en 2016

Letrozole Efficacy in the Treatment of Granulosa Cell Tumor of the Ovary: A Case Report ⬇️

artículo científico publicado el 19 de agosto de 2013

Long-term results of Ahmed glaucoma valve in association with intravitreal bevacizumab in neovascular glaucoma

artículo científico publicado en 2015

Management of stage III non-small cell lung cancer

artículo científico publicado en 2017

Managing Hodgkin lymphoma without chemotherapy: a novel, yet 'welcomed', challenge

artículo científico publicado en 2016

Mesotheliomas in Lebanon: Witnessing a Change in Epidemiology

artículo científico publicado en 2016

Metastatic gastric cancer treatment: Second line and beyond

artículo científico publicado en 2016

Negative predictive biomarkers of checkpoint inhibitors in hyper-progressive tumors

artículo científico publicado en 2017

Next revolution in molecular theranostics: personalized medicine for urologic cancers.

artículo científico

Novel mechanisms and approaches in the medical therapy of solid cancers

artículo científico publicado en 2015

Ocular and orbital side effects of ALK inhibitors: a review article

scientific article published on 29 May 2019

Optimum chemotherapy in the management of metastatic pancreatic cancer

scientific article published on March 2014

Osteonecrosis of the jaw during biyearly treatment with zoledronic acid for aromatase inhibitor associated bone loss in early breast cancer: A literature review

artículo científico publicado en 2015

Outcome of breast cancer screening: a Lebanese single institution experience

artículo científico publicado en 2014

PARP inhibitors: a tsunami of indications in different malignancies

artículo científico publicado en 2020

PD-L1: an unavoidable biomarker in advanced triple-negative breast cancer

scientific article published on 21 October 2019

Pancreatic small cell cancer.

artículo científico publicado en 2015

Pharmacodynamics, pharmacokinetics and clinical efficacy of neratinib in HER2-positive breast cancer and breast cancer with HER2 mutations

artículo científico publicado en 2016

Physical long-term side-effects in young adult cancer survivors: germ cell tumors model

artículo científico publicado en 2017

Poly-(ADP-ribose) polymerase inhibitors: paradigm shift in the first-line treatment of newly diagnosed advanced ovarian cancer

artículo científico publicado en 2020

Prognostic and predictive biomarkers in nonmetastatic colorectal cancers

artículo científico publicado en 2018

Rare side-effects of checkpoint inhibitors

artículo científico publicado en 2016

Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis

artículo científico publicado en 2016

Reply

Response of an ovarian granulosa cell tumor with everolimus and exemestane after initial response to letrozole

artículo científico publicado en 2017

Road map for pain management in pancreatic cancer: A review

artículo científico publicado en 2016

Side-effects of checkpoint inhibitor-based combination therapy

artículo científico publicado en 2016

Skin adverse events in recently approved targeted therapies in solid malignancies

artículo científico publicado en 2018

Successful eltrombopag treatment of refractory idiopathic thrombocytopenic purpura associated with Crohn disease

artículo científico publicado en 2014

Successful treatment of Evans syndrome with Tacrolimus

artículo científico publicado en 2014

TRK inhibitors: toward an era of agnostic targeted therapies in oncology

scientific article published on 01 August 2019

Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing?

artículo científico publicado en 2020

Targeted therapies in urothelial bladder cancer: a disappointing past preceding a bright future?

artículo científico publicado en 2019

Targeting EGFR mutation in non-small-cell lung cancer: challenges and future perspectives.

artículo científico publicado en 2016

Targeting HER2 in the management of potentially resectable gastric adenocarcinoma: what are oncologists waiting for?

artículo científico publicado en 2020

Telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities

artículo científico publicado en 2020

The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic

scientific article published on 08 April 2020

The Opinion of Oncologists on the Practice of Hypnosis among Cancer Patients in Lebanon

scientific article published on 12 August 2020

The emerging use of immune checkpoint blockade in the adjuvant setting for solid tumors: a review

scientific article published on 17 October 2019

The future of cancer research after COVID-19 pandemic: recession?

artículo científico publicado en 2020

The impact of the coronavirus pandemic on the management of cancer patients in Lebanon: a single institutional experience

artículo científico publicado en 2020

The merit of tyrosine kinase inhibitors in the adjuvant setting of high-risk renal cell carcinoma: a meta-analysis.

artículo científico publicado en 2018

The psychological challenges for oncological patients in times of COVID-19 pandemic: telemedicine, a solution?

scientific article published on 13 July 2020

The second wave of immune checkpoint inhibitor tsunami: advance, challenges and perspectives

artículo científico publicado en 2017

The use of everolimus to reverse tamoxifen resistance in men with metastatic breast cancer: a case report

artículo científico publicado en 2014

Treating cancer patients in times of COVID-19 pandemic: A virtual women cancers multidisciplinary meeting experience

artículo científico publicado en 2020

Trends in mammography utilization for breast cancer screening in a Middle-Eastern country: Lebanon 2005-2013.

artículo científico publicado en 2015

Triple-negative breast cancer: current perspective on the evolving therapeutic landscape

scientific article published on 31 July 2019

Type distribution of lymphomas in Lebanon: five-year single institution experience

artículo científico publicado en 2014

Unknown primary tumors: is there a future therapeutic role for immune checkpoint inhibitors?

artículo científico publicado en 2016

Untreated chronic lymphocytic leukemia in Lebanese patients: an observational study using standard karyotyping and FISH

article

Unusual presentation of nasopharyngeal carcinoma with rectal metastasis

artículo científico publicado en 2017

VITREORETINAL SURGERY WITH SILICONE OIL TAMPONADE IN PRIMARY UNCOMPLICATED RHEGMATOGENOUS RETINAL DETACHMENT: Clinical Outcomes and Complications

scientific article published on 01 October 2016

Validation of the EORTC QLQ-INFO 25 questionnaire in Lebanese cancer patients: Is ignorance a Bliss?

artículo científico publicado en 2015

Vulvar metastasis from bladder cancer

artículo científico publicado en 2015

Watch and Wait in Lebanese Chronic Lymphocytic Leukemia Patients: How Relevant is it?

artículo científico publicado en 2016

Where do immune checkpoint inhibitors stand in the management of thymic epithelial tumors?

scientific article published on 01 August 2018

Where does chemotherapy stands in the treatment of ampullary carcinoma? A review of literature

artículo científico publicado en 2016

Whole-exome and whole-genome sequencing in chronic lymphocytic leukemia: new biomarkers to target

artículo científico publicado en 2020

Why balls are not put inside the basket? A reflection on testicular cancer clinical trial design

artículo científico publicado en 2016

Will Testicular Germ Cell Tumors Remain Untargetable?

artículo científico publicado en 2016

Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?

artículo científico publicado en 2016

Will modern immunotherapies become the standard of care for advanced synchronous or metachronous cancers?

artículo científico publicado en 2015

Lista de obras de

A rare case of acute myeloid leukemia with t(12;19)(q13;q13)

ALK-rearranged adenocarcinoma transformed to small-cell lung cancer: a new entity with specific prognosis and treatment?

Acquired factor inhibitor in a patient with monoclonal gammopathy of undetermined significance responding to rituximab.

Acute myeloid leukemia transformed to a targetable disease

Adding checkpoint inhibitors to tyrosine kinase inhibitors targeting EGFR/ALK in non-small cell lung cancer: a new therapeutic strategy

Adenoid cystic carcinoma of the breast - an aggressive presentation with pulmonary, kidney, and brain metastases: a case report

Adjuvant tyrosine kinase inhibitors for renal cell carcinoma? No, thank you (at least for the present) reply

Agnostic biomarkers in gastrointestinal tumors: microsatellite instability and NTRK

Anal cancer treatment: current status and future perspectives

Are virus-induced cancers more sensitive to checkpoint inhibitors?

Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status

BRAFV600 mutant non-small-cell lung cancer resistant to Vemurafenib

Bioethical considerations for cancer patients care during the COVID-19 pandemic

Biomarkers for adverse events associated with immune checkpoint inhibitors

Bladder and vaginal transitional cell carcinoma: A case report

Bladder cancer knowledge in the Lebanese population: When ignorance could be harmful

Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence

Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO).

Central Macular Thickness Monitoring after a Taxane-Based Therapy in Visually Asymptomatic Patients.

Characteristic and outcomes of patients with pathologic complete response after preoperative treatment in borderline and locally advanced pancreatic adenocarcinoma: An AGEO multicentric retrospective cohort

Charcot-Marie-Tooth hereditary neuropathy revealed after administration of docetaxel in advanced breast cancer

Checkpoint inhibitors in bladder and renal cancers: results and perspectives.

Checkpoint inhibitors in gastrointestinal cancers: Expectations and reality

Checkpoint inhibitors in the treatment of brain metastases of non-small-cell lung cancer and melanoma

Complete Disappearance of Choroidal Metastasis from Lung Adenocarcinoma Treated with Bevacizumab and Chemotherapy

Concurrent driver mutations/rearrangements in non-small-cell lung cancer

Dermatologic adverse events of checkpoint inhibitors: what an oncologist should know

Diagnosis and treatment of lymphomas in the era of epigenetics

Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon

Dilemma of first line regimens in metastatic pancreatic adenocarcinoma

Disappearance of Upper Urinary Tract Urothelial Carcinoma after Treatment of a Borderline Brenner Tumor: Case Report and Literature Review

Distribution and Characteristics of Pulmonary Neuroendocrine Tumors: Single Institution Experience in Lebanon

Do checkpoint inhibitors provide new hope for management of metastatic penile carcinoma?

Do immune-related adverse events correlate with response to immune checkpoint inhibitors?

Double pancreatic and gastric adenocarcinomas: a rare association

EARLY INCREASE of CA 19-9 in ADVANCED PANCREATIC CANCER RECEIVING FOLFIRINOX. Is it a sign of efficacy?

EGFR mutation status in Middle Eastern patients with non-squamous non-small cell lung carcinoma: A single institution experience

Electronic patient-reported outcomes: a revolutionary strategy in cancer care

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib.

Epidemiologic and histologic characteristics of CNS lesions: a 20-year experience of a tertiary center in Lebanon

Express approval of immune checkpoint inhibitors: a conflict between science and finance

FOLFIRINOX: a new standard of care in the adjuvant setting of resectable pancreatic adenocarcinomas

Factor XIII deficiency revealed by spontaneous intramedullary hemorrhage: confirmation of a severe mutation

Finally, after decades, immune checkpoint inhibitors dethroned the standard of care of small-cell lung cancer

Gastrointestinal cancers in the era of theranostics: Updates and future perspectives

Geriatric cancer trends in the Middle-East: Findings from Lebanese cancer projections until 2025.

Histologic Distribution of Pulmonary Tumors in Lebanon: A 5-Year Single Institution Experience.

How and when adjuvant treatment should be intensified in stage III colorectal cancers?

Immune checkpoint inhibitors in ocular melanomas: contrasting efficacy with cutaneous melanomas

Immune checkpoint inhibitors renal side effects and management

Immune checkpoint inhibitors side effects and management

Immunotherapies in sarcoma: Updates and future perspectives

Immunotherapy: last bullet in platinum refractory germ cell testicular cancer

Impact of the new World Health Organization classification concept of neuroendocrine tumors

Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis

Improved survival in patients with CALR1 compared to CALR2 mutated primary myelofibrosis: a meta-analysis

Incidence and Risk Factors of Ocular Hypertension following Pars Plana Vitrectomy and Silicone Oil Injection

Informational Needs of Women with Breast Cancer Treated with Chemotherapy

Intravitreal bevacizumab for retinal capillary hemangioblastoma: A case series and literature review

Is gut microbiome a predictive marker to response to immune checkpoint inhibitors?

Is metastatic pancreatic cancer an untargetable malignancy?

Is ramucirumab still the only second-line treatment in metastatic gastric cancer?

Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma? A case report and literature review

Kidney cancer in Lebanon: a specific histological distribution?

Learning from the "tsunami" of immune checkpoint inhibitors in 2015.

Letrozole Efficacy in the Treatment of Granulosa Cell Tumor of the Ovary: A Case Report ⬇️

Long-term results of Ahmed glaucoma valve in association with intravitreal bevacizumab in neovascular glaucoma

Management of stage III non-small cell lung cancer

Managing Hodgkin lymphoma without chemotherapy: a novel, yet 'welcomed', challenge

Mesotheliomas in Lebanon: Witnessing a Change in Epidemiology

Metastatic gastric cancer treatment: Second line and beyond

Negative predictive biomarkers of checkpoint inhibitors in hyper-progressive tumors

Next revolution in molecular theranostics: personalized medicine for urologic cancers.

Novel mechanisms and approaches in the medical therapy of solid cancers

Ocular and orbital side effects of ALK inhibitors: a review article

Optimum chemotherapy in the management of metastatic pancreatic cancer

Osteonecrosis of the jaw during biyearly treatment with zoledronic acid for aromatase inhibitor associated bone loss in early breast cancer: A literature review

Outcome of breast cancer screening: a Lebanese single institution experience

PARP inhibitors: a tsunami of indications in different malignancies